Freenome (Seed)
Funding Details
- Awarder
- Inbox
- Date Award
- June 09, 2016
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $5,500,000
Company Info
- Founding Year
- 2016
- Founders
- Gabriel Otte
- Company Description
- Freenome is a biotechnology company that has pioneered the most comprehensive multiomics platform for early cancer detection. By combining a deep expertise in molecular biology with advanced computational biology and machine learning techniques to recognize disease-associated patterns among billions of circulating, cell-free biomarkers, Freenome is developing simple and accurate blood tests for early cancer detection and integrating the actionable insights into health systems to operationalize a machine learning feedback loop between care and science.
- Market
- Early cancer detection
- Location
- South San Francisco, California, USA
- Coinvestors
- Data Collective, Founders Fund, Third Kind Venture Capital